Kim P. Kamdar serves as Executive at CADENCE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Kim P. Kamdar has executed 16 insider transactions totaling $743.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 6, 2024 involved receiving (via award) 7,117 shares valued at $0.
Kim P. Kamdar currently holds 13,746 shares of CADENCE PHARMACEUTICALS INC (CADX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kim P. Kamdar has been a net buyer of CADX stock. They have purchased $377.4K and sold $366.0K worth of shares.
Kim P. Kamdar's most recent insider trade was on Jun 6, 2024, when they sold 7,117 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.62 |
| Discretionary |
| Aug 15, 2023 | OMIC | $106.0K | Sale | 200,000 | $0.53 | Discretionary |
| Aug 14, 2023 | OMIC | $44.5K | Sale | 77,991 | $0.57 | Discretionary |
| Aug 11, 2023 | OMIC | $212.2K | Sale | 353,657 | $0.60 | Discretionary |
| Jun 18, 2021 | EVFM | $11.7K | Purchase | 10,000 | $1.17 | Discretionary |
| Jun 1, 2021 | OMIC | $0 | Conversion | 4,395,633 | $N/A | Discretionary |
| Jun 12, 2020 | EVFM | $14.7K | Purchase | 5,000 | $2.94 | Discretionary |
| Aug 6, 2019 | OBLN | $50.0K | Purchase | 12,500 | $4.00 | Discretionary |
| Jul 23, 2019 | OBLN | $0 | Award | 78,125 | $N/A | Discretionary |
| May 22, 2019 | EVFM | $0 | Other | 4,287 | $N/A | Discretionary |
| May 21, 2019 | EVFM | $3.3K | Sale | 655 | $5.07 | Discretionary |
| Aug 23, 2018 | OBLN | $100.0K | Purchase | 54,945 | $1.82 | Discretionary |
| Oct 12, 2016 | OBLN | $201.0K | Purchase | 13,400 | $15.00 | Discretionary |
| Nov 17, 2014 | DRTX | $0 | Disposition | 6,250 | $N/A | Discretionary |
| Mar 19, 2014 | CADX | $385.0K | Disposition | 27,500 | $14.00 | Discretionary |